ProfileGDS4459 / ENSG00000167774
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 85% 86% 82% 77% 82% 81% 79% 78% 80% 80% 80% 82% 79% 82% 80% 68% 80% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 16.4785
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 26.4986
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 36.4682
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 45.6477
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 56.3382
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 66.1781
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 76.1479
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 86.0478
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 96.280
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 106.1780
GSM623474group B, liver allograft wedge biopsie placebo treatment 16.0980
GSM623475group B, liver allograft wedge biopsie placebo treatment 26.482
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.9979
GSM623477group B, liver allograft wedge biopsie placebo treatment 46.0682
GSM623478group B, liver allograft wedge biopsie placebo treatment 56.2980
GSM623479group B, liver allograft wedge biopsie placebo treatment 65.0668
GSM623480group B, liver allograft wedge biopsie placebo treatment 75.9380